Nephro Care India Limited (NSE:NEPHROCARE)
India · Delayed Price · Currency is INR 64.25
+1.40 (2.23%)
At close: Jul 31, 2026
Nephro Care India Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 887.35 | 887.35 | 460.31 | 272.31 | 170.93 | 34.24 |
Revenue Growth | 31.13% | 92.77% | 69.04% | 59.31% | 399.14% | 87.66% |
Gross Profit Gross Profit Growth | 475.25 | 475.25 | 251.19 | 157.91 | 108.64 | 15.55 |
Operating Income Operating Income Growth | 32.47 | 32.47 | 36.98 | 60.38 | 26.41 | 0.14 |
Net Income Net Income Growth | 33.69 | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Earnings Per Share EPS Growth | 2.04 | 2.04 | 2.38 | 3.73 | 2.37 | -0.03 |
EPS Growth | -1.06% | -14.29% | -36.14% | 57.26% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Ipd Services Ipd Services Growth | 433.05 | 433.05 | - | - | - | - |
Opd Services Opd Services Growth | 251.92 | 251.92 | - | - | - | - |
Sale of Medicines From Pharmacy Sale of Medicines From Pharmacy Growth | 294.31 | 294.31 | - | - | - | - |
Inter-segment Sales Inter-segment Sales Growth | -90.68 | -90.68 | - | - | - | - |
Unallocated Discount Unallocated Discount Growth | -1.25 | -1.25 | - | - | - | - |
Healthcare Facilities & Services Healthcare Facilities & Services Growth | - | - | 460.31 | 272.31 | 170.93 | 34.24 |
Total Total Growth | 887.35 | 887.35 | 460.31 | 272.31 | 170.93 | 34.24 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 165.02 | 165.02 | 206.58 | 78 | 23.17 | 6.09 |
Total Debt Total Debt Growth | - | - | - | - | 24.82 | 25.37 |
Net Cash (Debt) Net Cash Growth | 165.02 | 165.02 | 206.58 | 78 | -1.65 | -19.28 |
Net Cash Growth | 17.44% | -20.12% | 164.84% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 9.99 | 9.99 | 13.52 | 6.59 | -0.16 | -5.42 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 22.11 | 22.11 | 78.24 | 9.11 | 41.22 | 6.17 |
Capital Expenditures CapEx Growth | -78.06 | -78.06 | -298.04 | -32.89 | -5.05 | -28.93 |
Free Cash Flow Free Cash Flow Growth | -55.96 | -55.96 | -219.79 | -23.78 | 36.17 | -22.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 53.56% | 53.56% | 54.57% | 57.99% | 63.56% | 45.40% |
Operating Margin | 3.66% | 3.66% | 8.03% | 22.17% | 15.45% | 0.41% |
Pretax Margin | 5.23% | 5.23% | 10.49% | 22.52% | 15.08% | 0.01% |
Profit Margin | 3.80% | 3.80% | 7.90% | 16.20% | 13.88% | -0.29% |
FCF Margin | -6.31% | -6.31% | -47.75% | -8.73% | 21.16% | -66.44% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 31.50 | 25.33 | 57.61 | - | - | - |
PS Ratio | 1.19 | 0.96 | 4.55 | - | - | - |